Hillstar Bio Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
23
- Latest Deal Type
-
Series A
- Latest Deal Amount
-
$66.5M
- Investors
-
5
Hillstar Bio General Information
Description
Developer of autoimmune drugs intended to address unmet medical needs. The company's technique selectively targets and depletes pathogenic immune cells while sparing healthy ones, which addresses specific disease mechanisms by eliminating the underlying source and reducing the risks associated with chronic broad immunosuppression, enabling clients to offer the potential for durable relief and immune reset for patients with autoimmune conditions.
Contact Information
Website
www.hillstarbio.comCorporate Office
- 6 Tide Street
- Boston, MA 02210
- United States
Corporate Office
- 6 Tide Street
- Boston, MA 02210
- United States
Hillstar Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Early Stage VC (Series A) | 25-Mar-2025 | $66.5M | Completed | Pre-Clinical Trials |
Hillstar Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A |
Hillstar Bio Patents
Hillstar Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026170102-A1 | Humanized anti-tcrbv9 antibodies | Pending | 10-Feb-2025 |
Hillstar Bio Signals
Hillstar Bio Investors (5)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Droia Ventures | Venture Capital | Minority | ||
| Frazier Healthcare Partners | PE/Buyout | Minority | ||
| Hummingbird Bioscience | VC-Backed Company | Minority | ||
| LifeArc Ventures | Venture Capital | Minority | ||
| Novo Holdings | Venture Capital | Minority |
Hillstar Bio FAQs
-
When was Hillstar Bio founded?
Hillstar Bio was founded in 2023.
-
Where is Hillstar Bio headquartered?
Hillstar Bio is headquartered in Boston, MA.
-
What is the size of Hillstar Bio?
Hillstar Bio has 23 total employees.
-
What industry is Hillstar Bio in?
Hillstar Bio’s primary industry is Drug Discovery.
-
Is Hillstar Bio a private or public company?
Hillstar Bio is a Private company.
-
What is the current valuation of Hillstar Bio?
The current valuation of Hillstar Bio is .
-
What is Hillstar Bio’s current revenue?
The current revenue for Hillstar Bio is .
-
How much funding has Hillstar Bio raised over time?
Hillstar Bio has raised $66.5M.
-
Who are Hillstar Bio’s investors?
Droia Ventures, Frazier Healthcare Partners, Hummingbird Bioscience, LifeArc Ventures, and Novo Holdings have invested in Hillstar Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process